(Q37303602)

19 August 2017

1 reference

title

Control of blood pressure by the renin-angiotensin-aldosterone system (English)

1 reference

19 August 2017

Hall JE

1

1 reference

19 August 2017

publication date

1 August 1991

1 reference

19 August 2017

1 reference

19 August 2017

volume

14

1 reference

19 August 2017

issue

8 Suppl 4

1 reference

19 August 2017

page(s)

IV6-21; discussion IV51-5

1 reference

The renin-angiotensin system and long-term regulation of arterial pressure.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Role of renal hemodynamics and arterial pressure in aldosterone "escape"

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Intrarenal actions of converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Captopril-induced renal insufficiency and the role of sodium balance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Cardiovascular effects of angiotensin mediated by the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

THE ACTION OF PEPTIDES ON THE ADRENAL MEDULLA. RELEASE OF ADRENALINE BY BRADYKININ AND ANGIOTENSIN

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Chronic angiotensin II infusion decreases renal norepinephrine overflow in conscious dogs

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Aldosterone Production by Isolated Adrenal Glomenilosa Cells: Stimulation by Physiological Concentrations of Angiotensin II

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Angiotensin II: a potent regulator of acidification in the rat early proximal convoluted tubule

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Renal response to angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Mechanism of the blood pressure and renal hemodynamic effects of captopril

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Interactions of prostaglandins with the kallikrein-kinin and renin-angiotensin systems

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960141802

7 January 2021

Identifiers

DOI

10.1002/CLC.4960141802

0 references

1 reference